GABAERGIC LIGANDS AND THEIR USES
    88.
    发明申请

    公开(公告)号:US20190300534A1

    公开(公告)日:2019-10-03

    申请号:US16283926

    申请日:2019-02-25

    Abstract: Described herein are α3 or α2 or α2/α3 GABAergic receptor subtype selective ligands, pharmaceutical compositions, and methods of use of such ligands and compositions in treatment of anxiety disorders, epilepsy and schizophrenia with reduced sedative and ataxic side effects. In embodiments, such as α3 or α2 or α2/α3 GABAergic receptor subtype selective ligands lack ester linkages and may be thus relatively insensitive to hydrolysis by esterases.

    SNAPSHOT OPTICAL TOMOGRAPHY SYSTEM AND METHOD OF ACQUIRING AN IMAGE WITH THE SYSTEM

    公开(公告)号:US20190163132A1

    公开(公告)日:2019-05-30

    申请号:US16092256

    申请日:2017-05-04

    Inventor: Yongjin Sung

    Abstract: This disclosure discloses a method of creating a three-dimensional image of a sample using snapshot optical tomography. The method includes generating a plurality of beams incident on the sample simultaneously, acquiring a field image at a plane not conjugate to the sample plane using off-axis digital holography, extracting amplitude data and phase data for the field image, restoring the sharpness by backpropagating the field image using the extracted amplitude and phase data, acquiring a background image, extracting amplitude data and phase data for the background image, and reconstructing a three-dimensional image of the sample with the backpropagated field image and the background image. The method also includes arranging more than one imaging chains to remove the missing angle artefacts in optical tomography. Also disclosed are systems for performing the method.

Patent Agency Ranking